Nanolipogel
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
78
NCT04870411
Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics
Phase: N/A
Role: Collaborator
Start: May 12, 2021
Completion: Mar 13, 2022
Loading map...